MICROCHIP TECHNOLOGY INC (MCHP)
MICROCHIP TECHNOLOGY INC (MCHP)
| Cash Flow | 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 |
|---|---|---|---|---|
| Net income (loss) | 230 | -0.5 | 1,906.9 | 2,237.7 |
| Depreciation and amortization | 689.3 | 750.1 | 879.5 | 998.4 |
| Deferred income taxes | -64.6 | -143.3 | -27.2 | 205.5 |
| Share-based compensation expense related to equity incentive plans | 255.4 | 180.4 | 177.5 | 170.4 |
| Loss on settlement of debt | 0 | -1.7 | -12.2 | -8.3 |
| Amortization of debt discount | 27.2 | 64.8 | 37.5 | 7.2 |
| Amortization of debt issuance costs | 5.9 | 7.8 | 7.3 | 9.5 |
| Impairment of intangible assets | 4.1 | 0 | 1.8 | 1.8 |
| Other non-cash adjustment | NaN | NaN | NaN | 1.8 |
| Other | -17.5 | -63 | -26.1 | NaN |
| (increase) decrease in accounts receivable | 204.5 | -454 | -161.6 | 232.7 |
| Decrease in inventories | -264.3 | -31.6 | -12.8 | 483.2 |
| Increase (decrease) in accounts payable and accrued liabilities | 26 | -345.6 | -148.4 | 323.4 |
| Change in other assets and liabilities | 105.8 | 38.1 | 64.2 | -404.5 |
| Change in income tax payable | -147.7 | -1.8 | -38.5 | -28 |
| Net cash provided by operating activities | 962.1 | 898.1 | 2,892.7 | 3,621 |
| Proceeds from sales of assets | NaN | NaN | 0.4 | 0.9 |
| Other investing | -1.3 | -2.4 | NaN | NaN |
| Proceeds from capital-related government incentives | 5.1 | 0.4 | 6 | NaN |
| Investments in other assets | 110.8 | 164.6 | 113.4 | 114.2 |
| Capital expenditures | 91.1 | 126 | 285.1 | 486.2 |
| Net cash used in investing activities | -195.5 | -287.8 | -392.1 | -599.5 |
| Proceeds from borrowings on revolving credit facility | 0 | 68 | 6,271 | NaN |
| Repayments of revolving credit facility | 0 | 68 | 6,371 | NaN |
| Proceeds from borrowings on 2025 term loan facility | 0 | 0 | 750 | NaN |
| Repayments of 2025 term loan facility | 0 | 750 | NaN | NaN |
| Proceeds from borrowings on revolving credit facility-Revolving Credit Facility | NaN | NaN | NaN | 5,935 |
| Proceeds from issuance of commercial paper | 6,416.3 | 13,937.5 | 9,039.1 | NaN |
| Repayments of line of credit-Revolving Credit Facility | NaN | NaN | NaN | 7,234.1 |
| Repayments of commercial paper | 6,242.6 | 15,113.9 | 7,688.7 | NaN |
| Proceeds from issuance of senior notes | 0 | 1,992.2 | 994.7 | 0 |
| Repayment of senior notes | 1,200 | 1,000 | 3,400 | 0 |
| Repayment of bridge loan facility | NaN | NaN | NaN | 0 |
| Repayments of line of credit-Term Loan Facility | NaN | NaN | NaN | 0 |
| Proceeds from issuance of convertible debt | 900 | 1,250 | NaN | NaN |
| Payments on settlement of convertible debt | 0 | 672.2 | 132.8 | 170.4 |
| Issuance of series a preferred stock | 0 | 1,449.5 | NaN | NaN |
| Deferred financing costs | 16.6 | 19.7 | 3 | 0 |
| Purchase of capped call options | 68 | 160.1 | NaN | 0 |
| Proceeds from sale of common stock | 61.7 | 65.4 | 82.1 | 82.3 |
| Tax payments related to shares withheld for vested rsus | 51.4 | 57.6 | 61.1 | 75.8 |
| Repurchase of common stock | 0 | 96.5 | 982.1 | 945.8 |
| Payment of cash dividends on series a preferred stock | 108.5 | NaN | NaN | NaN |
| Payment of cash dividends | NaN | 975.7 | 911.5 | 695.3 |
| Payment of cash dividends on common stock | 984 | NaN | NaN | NaN |
| Capital lease payments | 1.6 | 1.6 | 1.6 | 0.8 |
| Other financing | -3.3 | -5.6 | NaN | NaN |
| Net cash used in financing activities | -1,298 | -158.3 | -2,414.9 | -3,104.9 |
| Net (decrease) increase in cash and cash equivalents | -531.4 | 452 | 85.7 | -83.4 |
| Cash and cash equivalents, at beginning of period | 771.7 | 319.7 | 234 | 317.4 |
| Cash and cash equivalents, at end of period | 240.3 | 771.7 | 319.7 | 234 |